Activation of NK cells and disruption of PD-L1/PD-1 axis: Two different ways for lenalidomide to block myeloma progression

Massimo Giuliani, Bassam Janji* (Main author), Guy Berchem

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

63 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Activation of NK cells and disruption of PD-L1/PD-1 axis: Two different ways for lenalidomide to block myeloma progression'. Together they form a unique fingerprint.

Medicine & Life Sciences